Regulation And Legal
Gufic Biosciences Assigned 69.7/100 ESG Rating
Gufic Biosciences discloses receipt of an independent ESG rating of 69.7/100 (Medium category) from SES ESG Research for FY 2025-26.
The rating was assigned based on publicly available information wit
